Damage to Nuclear DNA Shown to Correlate with Huntington’s Duration, Patient’s Ability to Function

The level of damage present in the DNA inside the cell nucleus — called nuclear DNA — correlates with disease duration and functional capacity in patients with Huntington’s disease, suggesting its potential use as a disease biomarker, a new study shows. The study, “Increased nuclear DNA damage precedes mitochondrial dysfunction in…

Scientists Identify New Huntington’s Disease Biomarkers in Mouse Study

Researchers identified several new biomarkers in mice that may help in the early diagnosis of Huntington’s disease in humans, according to a new study. These biomarkers may also be useful to evaluate patients’ responses to potential treatments. The Stanford University School of Medicine study, “Potential Biomarkers To Follow The…